Terumo (OTCMKTS:TRUMY) Reaches New 1-Year Low – Time to Sell?

Shares of Terumo Corp. (OTCMKTS:TRUMY) reached a new 52-week low on Tuesday . The company traded as low as $12.12 and last traded at $12.1267, with a volume of 49556 shares. The stock had previously closed at $12.56.

Analyst Ratings Changes

A number of research analysts have issued reports on TRUMY shares. Nomura raised shares of Terumo to a “hold” rating in a research note on Tuesday, February 24th. Zacks Research raised Terumo to a “hold” rating in a report on Thursday, April 9th. Two investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold”.

Terumo Price Performance

The business’s 50-day simple moving average is $13.09 and its 200 day simple moving average is $14.04. The company has a market capitalization of $17.97 billion, a P/E ratio of 21.00 and a beta of 0.62. The company has a current ratio of 1.51, a quick ratio of 0.89 and a debt-to-equity ratio of 0.07.

Terumo (OTCMKTS:TRUMY) last posted its quarterly earnings data on Friday, February 13th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). Terumo had a net margin of 11.74% and a return on equity of 9.01%. The company had revenue of $1.94 billion for the quarter, compared to analyst estimates of $1.82 billion. As a group, sell-side analysts anticipate that Terumo Corp. will post 0.58 EPS for the current year.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.